# Moonlighting Functions of Mammalian Peroxiredoxins in Cellular Signaling

**Authors:** Yosup Kim, Eun-Kyung Kim, Ho Hee Jang

PMC · DOI: 10.3390/antiox15020231 · Antioxidants · 2026-02-10

## TL;DR

This review explores how mammalian peroxiredoxins (Prdxs) have roles beyond being antioxidants, including sensing peroxides, regulating redox signaling, and acting as molecular chaperones.

## Contribution

The paper highlights the diverse post-translational modifications and isoform-specific functions of Prdxs, emphasizing their roles in cellular signaling and disease.

## Key findings

- Prdxs act as peroxide sensors and modulators of redox signaling through reversible hyperoxidation.
- Prdx isoforms have distinct subcellular localizations and functions in physiological and pathological processes.
- Post-translational modifications regulate Prdx activity and influence cellular signaling.

## Abstract

Peroxiredoxins (Prdxs) are a family of thiol-specific peroxidases that play a central role in maintaining intracellular redox homeostasis. In addition to their classical antioxidant activities, Prdxs function as peroxide sensors, modulators of redox signaling, and molecular chaperones. In this review, we summarize the peroxide-reducing activity, their redox-switch mechanism driven by reversible hyperoxidation, and the chaperone function that arises through oligomerization and accompanying structural changes. We also highlight that the Prdx1–Prdx6 isoforms exhibit distinct subcellular localizations and perform isoform-specific functions, thereby contributing to a wide range of physiological and pathological processes. Furthermore, we compile recent findings showing that diverse post-translational modifications (PTMs), including phosphorylation, acetylation, ubiquitination, glutathionylation, sumoylation, and S-nitrosylation, not only regulate Prdx activity but also contribute to cellular signaling processes. Overall, this review emphasizes that Prdxs are more than simple antioxidant enzymes: they serve as guardians of cellular redox balance and dynamic regulators of signaling networks, underscoring their potential as disease biomarkers and therapeutic targets.

## Linked entities

- **Genes:** PRDX1 (peroxiredoxin 1) [NCBI Gene 5052], PRDX6 (peroxiredoxin 6) [NCBI Gene 9588]

## Full-text entities

- **Genes:** COX2 (cytochrome c oxidase subunit II) [NCBI Gene 4513] {aka COII, MTCO2}, KLF2 (KLF transcription factor 2) [NCBI Gene 10365] {aka LKLF}, UBE3A (ubiquitin protein ligase E3A) [NCBI Gene 7337] {aka ANCR, AS, E6-AP, EPVE6AP, HPVE6A, PIX1}, PRDX4 (peroxiredoxin 4) [NCBI Gene 10549] {aka AOE37-2, AOE372, HEL-S-97n, PRX-4}, Prdx5 (peroxiredoxin 5) [NCBI Gene 113898] {aka Aoeb166}, Prdx3 (peroxiredoxin 3) [NCBI Gene 11757] {aka Aop1, D0Tohi1, Ef2l, Mer5, Prx3, SP22}, STAT3 (signal transducer and activator of transcription 3) [NCBI Gene 6774] {aka ADMIO, ADMIO1, APRF, HIES}, SRC (SRC proto-oncogene, non-receptor tyrosine kinase) [NCBI Gene 6714] {aka ASV, SRC1, THC6, c-SRC, p60-Src}, TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, PRKN (parkin RBR E3 ubiquitin protein ligase) [NCBI Gene 5071] {aka AR-JP, LPRS2, PARK2, PDJ}, APP (amyloid beta precursor protein) [NCBI Gene 351] {aka AAA, ABETA, ABPP, AD1, APPI, CTFgamma}, Il1b (interleukin 1 beta) [NCBI Gene 16176] {aka IL-1beta, Il-1b}, PRDX2 (peroxiredoxin 2) [NCBI Gene 7001] {aka HEL-S-2a, NKEF-B, NKEFB, PRP, PRX2, PRXII}, Rhot1 (ras homolog family member T1) [NCBI Gene 59040] {aka 2210403N23Rik, Arht1, C430039G08Rik, Miro1}, ATP6 (ATP synthase F0 subunit 6) [NCBI Gene 4508] {aka ATPase6, MTATP6}, CTH (cystathionine gamma-lyase) [NCBI Gene 1491] {aka CGL, CSE}, DUOX2 (dual oxidase 2) [NCBI Gene 50506] {aka LNOX2, NOXEF2, P138-TOX, TDH6, THOX2}, HDAC6 (histone deacetylase 6) [NCBI Gene 10013] {aka CPBHM, HD6, JM21, KDAC6, PPP1R90}, SUMO1 (small ubiquitin like modifier 1) [NCBI Gene 7341] {aka DAP1, GMP1, OFC10, PIC1, SMT3, SMT3C}, Prdx1 (peroxiredoxin 1) [NCBI Gene 18477] {aka MSP23, NkefA, OSF-3, OSF3, PAG, Paga}, Il6 (interleukin 6) [NCBI Gene 16193] {aka Il-6}, GSDMD (gasdermin D) [NCBI Gene 79792] {aka DF5L, DFNA5L, FKSG10, GSDMDC1}, EGF (epidermal growth factor) [NCBI Gene 1950] {aka HOMG4, URG}, MIR27B (microRNA 27b) [NCBI Gene 407019] {aka MIR-27b, MIRN27B, miRNA27B}, IL18 (interleukin 18) [NCBI Gene 3606] {aka IGIF, IL-18, IL-1g, IL1F4}, SIRT1 (sirtuin 1) [NCBI Gene 23411] {aka SIR2, SIR2L1, SIR2alpha}, CDK1 (cyclin dependent kinase 1) [NCBI Gene 983] {aka CDC2, CDC28A, P34CDC2}, CSE [NCBI Gene 1433], PRDX1 (peroxiredoxin 1) [NCBI Gene 5052] {aka MSP23, NKEF-A, NKEFA, PAG, PAGA, PAGB}, BNIP3 (BCL2 interacting protein 3) [NCBI Gene 664] {aka HABON, NIP3}, CP (ceruloplasmin) [NCBI Gene 1356] {aka AB073614, CP-2}, GLRX (glutaredoxin) [NCBI Gene 2745] {aka GRX, GRX1}, ZNF207 (zinc finger protein 207) [NCBI Gene 7756] {aka BuGZ, hBuGZ}, CASP1 (caspase 1) [NCBI Gene 834] {aka ICE, IL1BC, P45}, CBLL2 (Cbl proto-oncogene like 2) [NCBI Gene 158506] {aka CT138, HAKAIL, ZNF645}, APEX1 (apurinic/apyrimidinic endodeoxyribonuclease 1) [NCBI Gene 328] {aka APE, APE1, APEN, APEX, APX, HAP1}, PLA2G1B (phospholipase A2 group IB) [NCBI Gene 5319] {aka PLA2, PLA2A, PPLA2}, Nlrp3 (NLR family, pyrin domain containing 3) [NCBI Gene 216799] {aka AGTAVPRL, AII/AVP, Cias1, FCAS, FCU, MWS}, NFE2L2 (NFE2 like bZIP transcription factor 2) [NCBI Gene 4780] {aka IMDDHH, NRF2, Nrf-2}, COX3 (cytochrome c oxidase subunit III) [NCBI Gene 4514] {aka COIII, MTCO3}, PTS (6-pyruvoyltetrahydropterin synthase) [NCBI Gene 5805] {aka PTPS}, PRDX3 (peroxiredoxin 3) [NCBI Gene 10935] {aka AOP-1, AOP1, HBC189, MER5, PPPCD, PRO1748}, Tnf (tumor necrosis factor) [NCBI Gene 21926] {aka DIF, TNF-a, TNF-alpha, TNFSF2, TNFalpha, Tnfa}, MAPK1 (mitogen-activated protein kinase 1) [NCBI Gene 5594] {aka ERK, ERK-2, ERK2, ERT1, MAPK2, NS13}, GDPD5 (glycerophosphodiester phosphodiesterase domain containing 5) [NCBI Gene 81544] {aka GDE2, PP1665}, PRDX6 (peroxiredoxin 6) [NCBI Gene 9588] {aka 1-Cys, AOP2, HEL-S-128m, LPCAT-5, NSGPx, PRX}, TXN (thioredoxin) [NCBI Gene 7295] {aka TRDX, TRX, TRX1, TXN1, Trx80}, PTGS1 (prostaglandin-endoperoxide synthase 1) [NCBI Gene 5742] {aka COX1, COX3, PCOX1, PES-1, PGG/HS, PGHS-1}, CDK5 (cyclin dependent kinase 5) [NCBI Gene 1020] {aka LIS7, PSSALRE}, PTK2B (protein tyrosine kinase 2 beta) [NCBI Gene 2185] {aka CADTK, CAKB, FADK2, FAK2, PKB, PTK}, COX1 (cytochrome c oxidase subunit I) [NCBI Gene 4512] {aka COI, MTCO1}, PRDX5 (peroxiredoxin 5) [NCBI Gene 25824] {aka ACR1, AOEB166, B166, HEL-S-55, PLP, PMP20}, Prdx5 (peroxiredoxin 5) [NCBI Gene 54683] {aka AOEB166, AOPP, PLP, Pmp20, Prdx6, PrxV}, IL12A (interleukin 12A) [NCBI Gene 3592] {aka CLMF, IL-12A, NFSK, NKSF1, P35}, TXNRD1 (thioredoxin reductase 1) [NCBI Gene 7296] {aka GRIM-12, TR, TR1, TRXR1, TXNR, TXNR1}, CDC25C (cell division cycle 25C) [NCBI Gene 995] {aka CDC25, PPP1R60}, SRXN1 (sulfiredoxin 1) [NCBI Gene 140809] {aka C20orf139, Npn3, SRX, SRX1}, MAP3K5 (mitogen-activated protein kinase kinase kinase 5) [NCBI Gene 4217] {aka ASK1, MAPKKK5, MEKK5}, HMGB1 (high mobility group box 1) [NCBI Gene 3146] {aka HMG-1, HMG1, HMG3, SBP-1}
- **Diseases:** ischemic (MESH:D002545), cancer (MESH:D009369), Alzheimer's disease (MESH:D000544), lung cancer (MESH:D008175), neurotoxic (MESH:D020258), injury to (MESH:D014947), neurodegeneration (MESH:D019636), sarcopenia (MESH:D055948), inflammation (MESH:D007249), Parkinson's disease (MESH:D010300), mitochondrial injury (MESH:D028361), tubal or male factor infertility (MESH:D007248), ischemia (MESH:D007511), FCD (MESH:D000092222), seizure (MESH:D012640), hypoxia (MESH:D000860), Damage (MESH:D020263), NASH (MESH:D005235), drug-resistant epilepsy (MESH:D000069279), neurovascular injury (MESH:D013901), FCD type II (MESH:C537067), insulin resistance (MESH:D007333), acute liver injury (MESH:D017114), metastasis (MESH:D009362), colorectal cancer (MESH:D015179), middle cerebral artery occlusion (MESH:D020244), cardiomyocyte death (MESH:D003643), HCC (MESH:D006528), breast cancer (MESH:D001943)
- **Chemicals:** carbon tetrachloride (MESH:D002251), BCNU (MESH:D002330), oxygen (MESH:D010100), acetaminophen (MESH:D000082), Rosmarinic acid (MESH:C041376), sorafenib (MESH:D000077157), NO (MESH:D009569), S-nitrosoglutathione (MESH:D026422), sulfinic acid (MESH:D013441), phospholipids (MESH:D010743), H2O (MESH:D014867), nitrotyrosine (MESH:C002744), NADPH (MESH:D009249), RNS (MESH:D026361), CR (MESH:D002857), peroxide (MESH:D010545), thiol (MESH:D013438), 1-methyl-4-phenylpyridinium (MESH:D015655), S- (MESH:D013455), Cys-SOH (MESH:C100870), RGF (MESH:C559147), H2S (MESH:D006862), Ca2+ (-), H2O2 (MESH:D006861), disulfide (MESH:D004220), membrane lipid (MESH:D008563), Lys (MESH:D008239), ROS (MESH:D017382), glucose (MESH:D005947), GSH (MESH:D005978), rotenone (MESH:D012402), S-nitrosocysteine (MESH:C021315), peroxynitrite (MESH:D030421), ATP (MESH:D000255), Tubastatin A (MESH:C553587), persulfide (MESH:C051552), LPS (MESH:D008070), Palmitic acid (MESH:D019308), cysteine (MESH:D003545), sulfonic acid (MESH:D013451)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Rattus norvegicus (brown rat, species) [taxon 10116], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** A549 — Homo sapiens (Human), Lung adenocarcinoma, Cancer cell line (CVCL_0023), NCI-H1299 — Homo sapiens (Human), Lung large cell carcinoma, Cancer cell line (CVCL_0060), RKO — Homo sapiens (Human), Colon carcinoma, Cancer cell line (CVCL_0504), SW480 — Homo sapiens (Human), Colon adenocarcinoma, Cancer cell line (CVCL_0546), HeLa — Homo sapiens (Human), Human papillomavirus-related endocervical adenocarcinoma, Cancer cell line (CVCL_0030), SH-SY5Y — Homo sapiens (Human), Neuroblastoma, Cancer cell line (CVCL_0019)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12937771/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12937771/full.md

## References

90 references — full list in the complete paper: https://tomesphere.com/paper/PMC12937771/full.md

---
Source: https://tomesphere.com/paper/PMC12937771